Invexans S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 5,125.38 million compared to USD 3,804.27 million a year ago. Net income was USD 167.93 million compared to USD 134.98 million a year ago.

Basic earnings per share from continuing operations was USD 0.0033 compared to USD 0.0027 a year ago. Diluted earnings per share from continuing operations was USD 0.0033 compared to USD 0.0027 a year ago.